STERIS (STE) Stock
Key stats
- Market cap
- $24.89B
- Price / Earnings ratio
- 30.2x
- EPS (TTM)
- $8.46
- Volume
- Loading
- 52-week high
- $269.44
- 52-week low
- $195.14
- Dividend yield
- 1.01%
- Dividend amount (latest)
- $0.69
- EPS vs analyst estimate
- +4.7%Q2 FY26 · $2.47 vs $2.36
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with STE
Recent news

STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?
STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?
STE

2 Healthcare Technology Stocks for a Digital Health Boom
2 Healthcare Technology Stocks for a Digital Health Boom
STE

Reasons to Add STE Stock to Your Portfolio Right Now
Reasons to Add STE Stock to Your Portfolio Right Now
STE

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
STE
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 74.10
- MACD 12/26/9
- 9.81
- EMA 9 of MACD
- 7.21
- MACD histogram
- 2.60
- SMA 50
- $222.06
- Price above SMA 50
- EMA 50
- $228.75
- Price above EMA 50
- SMA 200
- $224.16
- Price above SMA 200
- EMA 200
- $229.63
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2026Earnings
The market is expecting earnings per share of $2.74 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?
STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?
STE

2 Healthcare Technology Stocks for a Digital Health Boom
2 Healthcare Technology Stocks for a Digital Health Boom
STE

Reasons to Add STE Stock to Your Portfolio Right Now
Reasons to Add STE Stock to Your Portfolio Right Now
STE

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
STE

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
STE

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
STE

STERIS Q1 Earnings Call Highlights
STERIS Q1 Earnings Call Highlights
STE

STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading
STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading
STE

5 Quality Stocks Set to Reward Investors With Dividend Hikes
5 Quality Stocks Set to Reward Investors With Dividend Hikes
STE

Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings
Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings
STE
News tone: automated (AI) classification of the article's content, not a price prediction.
About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. We help our customers create a healthier and safer world by providing innovative healthcare, life sciences and dental products and services.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel A. Carestio | President, CEO & Director | 1973 |
| Ms. Karen L. Burton | Senior VP, CFO & Chief Accounting Officer | 1968 |
| Mr. John Adam Zangerle | Senior VP, General Counsel & Secretary | 1967 |
| Ms. Mary Clare Fraser | SVP & Chief Human Resources Officer | 1970 |
| Mr. Cary L. Majors | Senior VP & President of Healthcare | 1975 |
| Ms. Julie Winter | Vice President of Investor Relations & Corporate Communications | — |
| Ms. Lindsey McGowan | VP, Chief Compliance & Quality Officer | — |
| Ms. Julia K. Madsen | Senior VP & GM of Life Sciences | 1965 |
| Mr. Andrew Xilas | Senior VP & GM of Dental | 1965 |
| Mr. Kenneth E. Kohler | Senior VP & GM of AST | 1963 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 74.10
- MACD 12/26/9
- 9.81
- EMA 9 of MACD
- 7.21
- MACD histogram
- 2.60
- SMA 50
- $222.06
- Price above SMA 50
- EMA 50
- $228.75
- Price above EMA 50
- SMA 200
- $224.16
- Price above SMA 200
- EMA 200
- $229.63
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $284.00
- Average
- $284.00
- High
- $284.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -6.0 | +12.9 | ||||||||||
| 2022 | -7.5 | +6.4 | +1.9 | -9.7 | +1.8 | -6.9 | +7.0 | -9.5 | -17.0 | +1.5 | +7.4 | -4.0 |
| 2023 | +11.3 | -12.3 | +1.5 | -1.0 | +4.1 | +11.1 | +2.9 | +2.5 | -5.0 | -2.6 | -5.6 | +8.0 |
| 2024 | +0.9 | +4.2 | -3.4 | -7.5 | +8.7 | -3.9 | +9.3 | +0.0 | -0.3 | -5.9 | -2.7 | -6.1 |
| 2025 | +9.0 | +0.4 | +1.8 | -0.4 | +10.3 | -0.8 | -6.7 | +8.0 | +2.2 | -2.3 | +12.2 | -3.6 |
| 2026 | +5.0 | -4.5 | -10.8 | -1.4 | -0.8 | -0.2 | +7.6 | +0.0 | -8.6 | +8.5 | +9.8 |



